EDP Sciences logo
Subscriber Authentication Point
Search
Menu
All issues Volume 17 (2022) Math. Model. Nat. Phenom., 17 (2022) 39 References
Issue
Math. Model. Nat. Phenom.
Volume 17, 2022
Coronavirus: Scientific insights and societal aspects
Article Number 39
Number of page(s) 20
DOI https://doi.org/10.1051/mmnp/2022024
Published online 09 September 2022
  1. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases, U.S. Science Brief: COVID-19 Vaccines and Vaccination, https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/fully-vaccinated-people.html, accessed: October 6, 2021. [Google Scholar]
  2. COVID-19 Vaccination status, https://ncv.kdca.go.kr/eng/, accessed: April 13, 2022. [Google Scholar]
  3. Korea Disease Control and Prevention Agency, Anounce about the adjustement of social distancing, http://ncov.mohw.go.kr/infoBoardView.do?brdId=3&brdGubun=32&dataGubun=&ncvContSeq=6009&contSeq=6009&board_id=&gubun=, accessed: October 14, 2021. [Google Scholar]
  4. Korea Disease Control and Prevention Agency; Korean situation report of COVID-19; 2021 October 27, http://ncov.mohw.go.kr/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6043&contSeq=6043& board_id=312&gubun=ALL, accessed: October 27, 2021. [Google Scholar]
  5. Korea Disease Control and Prevention Agency; Korean situation report of COVID-19; 2021 October 8, http://ncov.mohw.go.kr/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=5989&contSeq=5989&board_id=312&gubun=ALL, accessed: October 14, 2021. [Google Scholar]
  6. Korea Disease Control and Prevention Agency; Proportions of variants among sampled genome sequencing in Korea, https://kdca.go.kr/contents.es?mid=a20107040000, accessed: October 27, 2021. [Google Scholar]
  7. Korea Disease Control and Prevention Agency, PUBLIC HEALTH WEEKLY REPORT, PHWR (Vol. 14, No. 17, 2021), https://www.kdca.go.kr/board/board.es?mid=a30501000000&bid=0031&list_no=713112&act=view, accessed: October 21, 2021. [Google Scholar]
  8. Korea Disease Control and Prevention Agency, PUBLIC HEALTH WEEKLY REPORT, PHWR (Vol. 14, No. 37, 2021), https://www.kdca.go.kr/board/board.es?mid=a30501000000&bid=0031&list_no=716914&act=view#, accessed: October 21, 2021. [Google Scholar]
  9. Korea Disease Control and Prevention Agency, Questions and answers about COVID-19 vaccines, criteria for the implementation of COVID-19 vaccination, https://ncv.kdca.go.kr/menu.es?mid=a12207000000, accessed: October 14, 2021. [Google Scholar]
  10. Korea Disease Control and Prevention Agency; Who will have vaccine first?, https://ncv.kdca.go.kr/menu.es?mid=a10117010000, accessed: October 14, 2021. [Google Scholar]
  11. Ministry of Education, Announce about school operation plan after Chuseok holiday, https://www.korea.kr/news/policyNewsView.do?newsId=148878606, accessed: October 14, 2021. [Google Scholar]
  12. Ministry of Health and Welfare, Republic of Korea. Coronavirus disease 2019 (COVID-19), http://ncov.mohw.go.kr/en/, accessed: October 6, 2021. [Google Scholar]
  13. National Institute for Mathematical Sciences, COVID-19 forecasts using mathematical modeling, https://www.nims.re.kr/research/post/covid19_2/34405, accessed: October 14, 2021. [Google Scholar]
  14. The Ministry of Health and Welfare, Plan of the step-by-step recovery from COVID-19, http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&page=1&CONT_SEQ=368237, accessed: October 14, 2021. [Google Scholar]
  15. WHO Situation Reports, https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—5-october-2021, accessed: October 6, 2021. [Google Scholar]
  16. YTN science, Delta variant takes 96.7% among variants and number of cases for a week was 2555, 7467 in total, https://science.ytn.co.kr/program/program_view.php?s_mcd=0082&key=202108101604183996&page=2, accessed: October 14, 2021. [Google Scholar]
  17. J.P. Arcede, R.L. Caga-Anan, C.Q. Mentuda and Y. Mammeri, Accounting for symptomatic and asymptomatic in a SEIR-type model of COVID-19. Math. Modell. Nat. Phenom. 15 (2020) 34. [CrossRef] [EDP Sciences] [Google Scholar]
  18. E. Augeraud-Véron, Lifting the COVID-19 lockdown: different scenarios for France. Math. Modell. Nat. Phenom. 15 (2020) 40. [CrossRef] [EDP Sciences] [Google Scholar]
  19. L. Bian, Q. Gao, F. Gao, Q. Wang, Q. He, X. Wu, Q. Mao, M. Xu and Z. Liang, Impact of the Delta variant on vaccine efficacy and response strategies. Exp. Rev. Vacc. 0 (2021) 1—9. [Google Scholar]
  20. G. Bianchin, E. Dall’Anese, J.I. Poveda, D. Jacobson, E.J. Carlton and A.G. Buchwald, Novel use of online optimization in a mathematical model of COVID-19 to guide the relaxation of pandemic mitigation measures. Sci. Rep. 12 (2022) 1—14. [CrossRef] [Google Scholar]
  21. M.A. Billah, M.M. Miah and M.N. Khan, Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence. PloS One 15 (2020) e0242128. [CrossRef] [PubMed] [Google Scholar]
  22. F. Campbell, B. Archer, H. Laurenson-Schafer, Y. Jinnai, F. Konings, N. Batra, B. Pavlin, K. Vandemaele, M.D. Van Kerkhove, T. Jombart et al., Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Eurosurveillance 26 (2021) 2100509. [CrossRef] [Google Scholar]
  23. G. Chowell, Fitting dynamic models to epidemic outbreaks with quantified uncertainty: a primer for parameter uncertainty, identifiability, and forecasts. Infect. Disease Model. 2 (2017) 379–398. [CrossRef] [Google Scholar]
  24. K. Dougherty, M. Mannell, O. Naqvi, D. Matson and J. Stone, SARS-CoV-2 B. 1.617. 2 (Delta) variant COVID-19 outbreak associated with a gymnastics facility—Oklahoma, April—May 2021. Morb. Mort. Weekly Rep. 70 (2021) 1004. [CrossRef] [PubMed] [Google Scholar]
  25. J. Jang, M.-J. Hwang, S.Y. Park, S.-S. Kim, J. Park, H. Yeom, S.B. Park and K. Donghyoks, Trends in COVID-19 cases among children and adolescents aged 0-18 years in the Republic of Korea. Korea Dis. Control Prev. Agency: Weekly Health Dis. 14 (2021). [Google Scholar]
  26. M.J. Keeling, E.M. Hill, E.E. Gorsich, B. Penman, G. Guyver-Fletcher, A. Holmes, T. Leng, H. McKimm, M. Tamborrino, L. Dyson et al., Predictions of COVID-19 dynamics in the UK: Short-term forecasting and analysis of potential exit strategies. PLoS Comput. Biol. 17 (2021) e1008619. [CrossRef] [Google Scholar]
  27. M. Ki et al., Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol. Health 42 (2020). [Google Scholar]
  28. Y. Ko, J. Lee, Y. Kim, D. Kwon and E. Jung, COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea. Int. J. Environ. Res. Public Health 18 (2021) 6469. [CrossRef] [Google Scholar]
  29. Y. Ko, J. Lee, Y. Kim, D. Kwon and E. Jung, COVID-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the Republic of Korea. Int. J. Environ. Res. Public Health 18 (2021) 10.3390/ijerph18126469. [Google Scholar]
  30. Y. Ko, J. Lee, Y. Seo and E. Jung, Risk of COVID-19 transmission in heterogeneous age groups and effective vaccination strategy in Korea: a mathematical modeling study. EpiH (2021). [Google Scholar]
  31. Y.-H. Lee, C.M. Hong, D.H. Kim, T.H. Lee and J. Lee, Clinical course of asymptomatic and mildly symptomatic patients with coronavirus disease admitted to community treatment centers, South Korea. Emerg. Infect. Dis. 26 (2020) 2346. [CrossRef] [PubMed] [Google Scholar]
  32. J. Lopez Bernal, N. Andrews, C. Gower, E. Gallagher, R. Simmons, S. Thelwall, J. Stowe, E. Tessier, N. Groves, G. Dabrera et al., Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant. N. Engl. J. Med. (2021) 585–594. [CrossRef] [PubMed] [Google Scholar]
  33. E. Mahase, Delta variant: What is happening with transmission, hospital admissions, and restrictions? (2021). [Google Scholar]
  34. S. Marino, I.B. Hogue, C.J. Ray and D.E. Kirschner, A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 254 (2008) 178–196. [CrossRef] [Google Scholar]
  35. A. Moussaoui and P. Auger, Prediction of confinement effects on the number of Covid-19 outbreak in Algeria. Math. Model. Nat. Phenom. 15 (2020) 37. [CrossRef] [EDP Sciences] [Google Scholar]
  36. H. Nishiura and G. Chowell, The Effective Reproduction Number as a Prelude to Statistical Estimation of Time-Dependent Epidemic Trends, 103–121, Springer Netherlands, Dordrecht (2009). [Google Scholar]
  37. H.K. Park, J.H. Ham, D.H. Jang, J.Y. Lee and W.M. Jang, Political ideologies, government trust, and COVID-19 VACCINE HESITANCY in South Korea: a cross-sectional survey. Int. J. Environ. Res. Public Health 18 (2021) 10655. [CrossRef] [Google Scholar]
  38. T.A. Perkins and G. Espana, Optimal control of the COVID-19 pandemic with non-pharmaceutical interventions. Bull. Math. Biol. 82 (2020) 1–24. [CrossRef] [MathSciNet] [Google Scholar]
  39. G. Rainisch, E.A. Undurraga and G. Chowell, A dynamic modeling tool for estimating healthcare demand from the COVID19 epidemic and evaluating population-wide interventions. Int. J. Infectious Dis. 96 (2020) 376–383. [CrossRef] [Google Scholar]
  40. R. Rowthorn and J. Maciejowski, A cost-benefit analysis of the COVID-19 disease. Oxford Rev. Econ. Policy 36 (2020) S38–S55. [CrossRef] [Google Scholar]
  41. P. Van den Driessche and J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 180 (2002) 29–48. [Google Scholar]
  42. Y. Wang, R. Chen, F. Hu, Y. Lan, Z. Yang, C. Zhan, J. Shi, X. Deng, M. Jiang, S. Zhong et al., Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China. EClinicalMedicine 40 (2021) 101129. [CrossRef] [PubMed] [Google Scholar]
  43. WHO et al., Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief, 09 July 2020. Tech. rep., World Health Organization (2020). [Google Scholar]
  44. J. Yang, G. Wang, S. Zhang, F. Xu and X. Li, Analysis of the age-structured epidemiological characteristics of SARS-COV-2 transmission in mainland China: an aggregated approach. Math. Modell. Nat. Phenom. 15 (2020) 39. [CrossRef] [EDP Sciences] [Google Scholar]
  45. K. Youngwha, K. Yuyeon, H. Yum, J. Jang, I. Hwang, G. Park, Y. Park, S. Lee and D. Kwon, Annual COVID-19 occurrence report. Korea Disease Control and Prevention Agency: Weekly health and diseases 14 (2021). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.